Quick summary
N-Acetyl Semax Amidate is the most potent and bioavailable form of Semax, with acetyl and amide modifications that extend the half-life from minutes to an estimated 6-12 hours. It is the preferred Semax variant for BDNF upregulation and cognitive enhancement in biohacking protocols.
Overview
N-Acetyl Semax Amidate is a modified analog of Semax, itself derived from the ACTH(4-7) fragment. It is considered the most potent and bioavailable form of Semax, incorporating both N-terminal acetylation and C-terminal amidation to resist enzymatic degradation. Used intranasally, it is studied for cognitive enhancement, neuroprotection, BDNF upregulation, and focus and mood improvement.
Mechanism of action
N-Acetyl Semax Amidate modulates neurotrophic and neurogenic signaling primarily through upregulation of brain-derived neurotrophic factor (BDNF) and its receptor TrkB, as well as nerve growth factor (NGF) and GAP-43. These effects promote neuroplasticity, synaptic density, and long-term potentiation. It also influences the melanocortin system via partial ACTH-receptor agonism, which affects mood, attention, and stress response. The acetyl and amide modifications substantially extend half-life compared to unmodified Semax (estimated 6–12 hours vs. 2–4 hours) by blocking aminopeptidase and carboxypeptidase cleavage sites. Dopaminergic and serotonergic modulation has been reported in preclinical models.
Dosing protocols
| Purpose | Route | Dosage | Frequency | Notes |
|---|---|---|---|---|
| cognitive enhancement and neuroprotection (research) | nasal | 300–900 mcg | once to twice daily | Start at 300 mcg (1 pump of 0.3% solution). Common formulations: 0.1% (300 mcg/pump) and 0.3% (300 mcg/pump). Cycle 4–8 weeks with breaks. Research use only. |
Dosing information is for educational purposes only. Consult a qualified healthcare professional before using any peptide.
Research summary
Semax and its analogs have been approved in Russia for stroke recovery, cognitive impairment, and optic nerve disease. Human studies (primarily Russian) demonstrate improvements in attention, processing speed, and memory consolidation. Animal models show neuroprotective effects following ischemic injury, increased BDNF expression in the hippocampus, and reduced neuroinflammation. N-Acetyl Semax Amidate's enhanced pharmacokinetics make it the preferred form in community biohacking protocols, though Western double-blind RCT data specific to this analog remain limited as of 2026.[1][2][3][4][5]
Evidence grading
Each claimed benefit is graded by the strength of available evidence. Grades reflect study quality, not effect size.
Strong = multiple RCTs · Moderate = limited trials or observational · Preliminary = animal or in vitro only · Insufficient = anecdotal or no published data
Side effects
Side effects vary by individual. This is not an exhaustive list. Report unusual symptoms to a healthcare professional.
Common stacks
Peptides commonly paired with N-Acetyl Semax Amidate for synergistic effects.
Legal status
Not FDA-approved. Available from US research peptide suppliers as a research compound. Approved as a drug in Russia (marketed as Semax). Not a scheduled substance in the US. Legal status may vary by country.
Sourcing & access
Research compound
N-Acetyl Semax Amidate is classified as a research compound. Regulatory status varies by jurisdiction. Always verify current legal status and source from vendors providing third-party certificates of analysis (COA).
Frequently asked questions
N-Acetyl Semax Amidate is a modified analog of Semax with both N-terminal acetylation and C-terminal amidation. These modifications resist enzymatic degradation, substantially extending the half-life compared to unmodified Semax and making it the most potent form available.
The acetyl and amide modifications block aminopeptidase and carboxypeptidase cleavage sites, extending the estimated half-life from 2-4 hours to 6-12 hours. This enhanced pharmacokinetics results in stronger and longer-lasting BDNF upregulation and cognitive effects.
It is administered intranasally using a spray, typically starting at 300 mcg per dose once to twice daily. Common formulations come in 0.1 percent and 0.3 percent solutions. Cycles of 4 to 8 weeks with breaks are standard.
It upregulates BDNF and its receptor TrkB, as well as NGF and GAP-43, promoting neuroplasticity and synaptic density. It also modulates the dopaminergic and serotonergic systems, affecting mood, attention, and stress response.
Reported side effects include nasal irritation or congestion, headache, fatigue after high doses, vivid dreams, and mild anxiety at high doses. The side effect profile is generally mild compared to stimulant-based cognitive enhancers.
Research references
- Influence of the N-terminus Acetylation of Semax, a Synthetic Analogue of ACTH(4-10), on Melanocortin Receptor Selectivity and ActivityPubMed
- Semax, an Analog of ACTH(4-10) with Cognitive Effects, Regulates BDNF and trkB Expression in the Rat HippocampusPubMed
- Neuroprotective and Antiamnesic Effects of Semax during Experimental Ischemic Infarction of the Cerebral CortexPubMed
- Effectiveness of Semax in Acute Period of Hemispheric Ischemic Stroke (a Clinical and Electrophysiological Study)PubMed
- The Neuroprotective Effects of Semax in Conditions of MPTP-Induced Lesions of the Brain Dopaminergic SystemPubMed